Skip to content

Erasca, Inc. ERAS Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
Tango Therapeutics logo
Tango TherapeuticsTNGX
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s operating lease right-of-use assets in other assets?
Erasca, Inc. (ERAS) reported operating lease right-of-use assets in other assets of $28.27M in Q1 2026.
How has Erasca, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
Erasca, Inc.'s operating lease right-of-use assets in other assets decreased by 10.3% year-over-year, from $31.53M to $28.27M.
What is the long-term trend for Erasca, Inc.'s operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Erasca, Inc.'s operating lease right-of-use assets in other assets has grown at a 67.1% compound annual growth rate (CAGR), from $2.23M to $29.03M.